Insulin-mediated activation of activator protein-1 through the mitogen-activated protein kinase pathway stimulates collagenase-1 gene transcription in the MES 13 mesangial cell line

Journal of Molecular Endocrinology

Volumn 33, Issue 1, 2004, Pages 263-280

  Ayala, J E ^a   Boustead, J N ^a   Chapman, S C ^a   Svitek, C A ^a   Oeser, J K ^a   Robey, R B ^b   O'Brien, Richard M ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE; COLLAGENASE 1; INSULIN; MATRIX METALLOPROTEINASE; MITOGEN ACTIVATED PROTEIN KINASE; SCLEROPROTEIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; TRANSCRIPTION FACTOR FRA 2; TRANSCRIPTION FACTOR JUNB; TRANSCRIPTION FACTOR JUND; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DIABETIC NEPHROPATHY; ENZYME ACTIVATION; ENZYME INHIBITION; EXTRACELLULAR MATRIX; FUSION GENE; GENE EXPRESSION; GLOMERULUS BASEMENT MEMBRANE; HUMAN; HUMAN CELL; HYPERGLYCEMIA; INSULIN BINDING; INSULIN RESPONSE; MESANGIUM CELL; MUTATIONAL ANALYSIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DEGRADATION; PROTEIN ISOLATION; PROTEIN MOTIF; PROTEIN SYNTHESIS; TRANSCRIPTION INITIATION;

ANIMALS; ARTIFICIAL GENE FUSION; BASE SEQUENCE; CELL LINE; COLLAGENASES; DNA PRIMERS; GLOMERULAR MESANGIUM; HUMANS; INSULIN; MAP KINASE SIGNALING SYSTEM; MICE; PLASMIDS; PROMOTER REGIONS (GENETICS); TRANSCRIPTION FACTOR AP-1; TRANSCRIPTION, GENETIC;

EID: 4444313481     PISSN: 09525041     EISSN: None     Source Type: Journal    
DOI: 10.1677/jme.0.0330263     Document Type: Article

References (88)

1. Abrass CK, Raugi GJ, Gabourel LS & Lovett DH 1988 Insulin and insulin-like growth factor I binding to cultured rat glomerular mesangial cells. Endocrinology 123 2432-2439.
2. Andrews NC & Faller DV 1991 A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Research 19 2499.
3. Angel P & Karin M 1991 The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochimica et Biophysica Acta 1072 129-157.
4. Arnqvist HJ, Ballermann BJ & King GL 1988 Receptors for and effects of insulin and IGF-I in rat glomerular mesangial cells: American Journal of Physiology 251 C411-C416.
5. Ayala JE, Streeper RS, Svitek CA, Goldman JK, Oeser JK & O'Brien RM 2002 Accessory elements, flanking DNA sequence, and promoter context play key roles in determining the efficacy of insulin and phorbol ester signaling through the malic enzyme and collagenase-1 AP-1 motifs. Journal of Biological Chemistry 277 27935-27944.
6. Baumhueter S, Mendel DB, Conley PB, Kuo CJ, Turk C, Graves MK, Edwards CA, Courtois G & Crabtree GR 1990 HNF-1 shares three sequence motifs with the POU domain proteins and is identical to LF-B1 and APF. Genes and Development 4 372-379.
7. Benbow U & Brinckerhoff CE 1997 The AP-1 site and MMP gene regulation: what is all the fuss about? Matrix Biology 15 519-526.
8. Bergman MR, Cheng S, Honbo N, Piacentini L, Karliner JS & Lovett DH 2003 A functional activating protein 1 (AP-1) site regulates matrix metalloproteinase 2 (MMP-2) transcription by cardiac cells through interactions with JunB-Fra1 and JunB-FosB heterodimers. Biochemical Journal 369 485-496.
9. Birkedal-Hansen H 1993 Role of matrix metalloproteinases in human periodontal diseases, Journal of Periodontology 64 474-484.
10. Bischof LJ, Martin CC, Svitek CA, Stadelmaier BT, Hornbuckle LA, Goldman JK, Oeser JK, Hutton JC & O'Brien RM 2001 Characterization of the mouse islet-specific glucose-6-phosphatase catalytic subunit-related protein gene promoter by in situ footprinting. Correlation with fusion gene expression in the islet derived bTC-3 and hamster insulinoma tumor cell lines. Diabetes 50 502-514
11. Borden P & Heller RA 1997 Transcriptional control of matrix metalloproteinases and the tissue inhibitors of matrix. metalloproteinases. Critical Reviews in Eukaryotic Gene Expression 7 159-178.
12. Brinckerhoff CE & Matrisian LM 2002 Matrix metalloproteinases: a tail of a frog that became a prince. Nature Reviews. Molecular Cell Biology 3 207-214.
13. Chapman SC, Ayala JE, Streeper RS, Culbert AA, Eaton EM, Svitek CA, Goldman JK, Tavare JM & O'Brien RM 1999 Multiple promoter elements are required for the stimulatory effect of insulin on human collagenase-1 gene transcription. Selective effects on activator protein-1 expression may explain the quantitative difference in insulin and phorbol ester action. Journal of Biological Chemistry 274 18625-18634.
14. Choi BH, Park CJ & Rho HM 1998 Insulin activates the hepatitis B virus X gene through the activating protein-1 binding site in HepG2 cells. DNA Cell Biology 17 951-956.
15. Coy PE, Taneja N, Lee I, Hecquet C, Bryson JM & Robey RB 2002 LPA is a novel lipid regulator of mesangial cell hexokinase activity and HKII isoform expression. American Journal of Physiology; Renal Physiology 283 F271-F279.
16. Creemers EE, Cleutjens JP, Smits JF & Daemen MJ 2001 Matrix metalloproteinase inhibition after myocardial infarction: a new approach to prevent heart failure? Circulation Research 89 201-210.
17. Crofford OB 1995 Diabetes control and complications. Annual Reviews in Medicine 46 267-279.
18. Culbert AA & Tavare JM 2002 Multiple signalling pathways mediate insulin-stimulated gene expression in 3T3-L1 adipocytes. Biochimica et Biophysica Acta 1578 43-50.
19. Cusi K, Maezono K, Osman A, Pendergrass M, Parti ME, Pratipanawatr T, DeFronzo RA, Kahn CR & Mandarino LJ 2000 Insulin resistance differentially affects the PI 3-kinase- and MAP kinase-mediated signaling in human muscle. Journal of Clinical Investigation 105 311-320.
20. Daniel PB, Walker WH & Habener JF 1998 Cyclic AMP signaling and gene regulation. Annual Reviews in Nutrition 18 353-383.
21. Duncia JV, Santella JB 3rd, Higley CA, Pitts WJ, Wityak J, Frietze WE, Rankin FW, Sun JH, Earl RA, Tabaka AC et al., 1998 MEK inhibitors: the chemistry and biological activity of U0126, its analogs, and cyclization products. Bioorganic Medicinal and Chemistry Letters 8 2839-2844.
22. Falvo JV, Parekh BS, Lin CH, Fraenkel E & Maniatis T 2000 Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation. Molecular and Cellular Biology 20 4814-4825.
23. Favata MF, Horiuchi KY, Manos EJ, Daulerio AJ, Stradley DA, Feeser WS, Van Dyk DE, Pitts WJ, Earl RA, Hobbs F et al. 1998 Identification of a novel inhibitor of mitogen-activated protein kinase kinase. Journal of Biological Chemistry 273 18623-18632.
24. Fry CJ & Farnham PJ 1999 Context-dependent transcriptional regulation. Journal of Biological Chemistry 274 29583-29586.
25. Griffiths MR, Black EJ, Culbert AA, Dickens M, Shaw PE, Gillespie DA & Tavare JM 1998 Insulin-stimulated expression of c-fos, fra1 and c-jun accompanies the activation of the activator protein-1 (AP-1) transcriptional complex. Biochemical Journal 335 19-26.
26. Higuchi R, Krummel B & Saiki RK 1988 A general method of in vitro preparation and specific mutagenesis of DNA fragments: study of protein and DNA interactions. Nucleic Acids Research 16 7351-7367.
27. Horton JD, Goldstein JL, & Brown MS 2002 SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. Journal of Clinical Investigation 109 1125-1131.
28. Hurd TW, Culbert AA, Webster KJ & Tavare JM 2002 Dual role for mitogen-activated protein kinase (Erk) in insulin-dependent regulation of Fra-1 (for-related antigen-1) transcription and phosphorylation. Biochemical Journal 368 573-580.
29. Hutton JC, Peshavaria M, Johnston CF, Ravazzola M & Orci L 1988 Immunolocalization of betagranin: a chromogranin A-related protein of the pancreatic B-cell. Endocrinology 122 1014-1020.
30. Jacoby DB, Zilz ND & Towle HC 1989 Sequences within the 5′-flanking region of the S14 gene confer responsiveness to glucose in primary hepatocytes. Journal of Biological Chemistry 264 17623-17626.
31. Kim JJ & Accili D 2002 Signalling through IGF-I and insulin receptors: where is the specificity? Growth Hormone and IGF Research 12 84-90.
32. Lenz O, Elliot SJ & Stetler-Steveuson WG 2000 Matrix metalloproteinases in renal development and disease. Journal of the American Society of Nephrology 11 574-581.
33. Leu JI, Crissey MA, Leu JP, Ciliberto G & Taub R 2001 Interleukin-6-induced STAT3 and AP-1 amplify hepatocyte nuclear factor 1-mediated transactivation of hepatic genes, an adaptive response to liver injury. Molecular and Cellular Biology 21 414-424.
34. Lin F, Kolluri SK, Chen GQ & Zhang XK 2002 Regulation of retinoic acid-induced inhibition of AP-1 activity by orphan receptor chicken ovalbumin upstream promoter-transcription factor. Journal of Biological Chemistry 277 21414-21422.
35. Lucas PC & Granner DK 1992 Hormone response domains in gene transcription. Annual Reviews in Biochemistry 61 1131-1173.
36. Lupia E, Elliot SJ, Lenz O, Zheng F, Hattori M, Striker GE & Striker LJ 1999 IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: implications for diabetic nephropathy. Diabetes 48 1638-1644.
37. MacKay K, Striker LJ, Elliot S, Pinkert CA, Brinster RL & Striker GE 1988 Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney International 33 677-684.
38. McLennan SV, Kelly DJ, Cox AJ, Cao Z, Lyons JG, Yue DK & Gilbert RE 2002 Decreased matrix degradation in diabetic nephropathy: effects of ACE inhibition on the expression and activities of matrix metalloproteinases. Diabetologia 45 268-275.
39. Maile S, Zimmermann B, Ketteler M & Merker HJ 2000 The morphology of mesangial cells cultured at high density and in collagen gels. Histology and Histopathology 15 403-414.
40. Mamounas M, Ross S, Luong CL, Brown E, Coulter K, Carroll G & Englesberg E 1991 Analysis of the genes involved in the insulin transmembrane mitogenic signal in Chinese hamster ovary cells, CHO-K1, utilizing insulin-independent mutants. PNAS 88 3530-3534.
41. Martin CC, Oeser JK, Svitek CA, Hunter SI, Hutton JC & O'Brien RM 2002 Identification and characterization of a human cDNA and gene encoding a ubiquitously expressed glucose-6-phosphatase catalytic subunit-related protein. Journal of Molecular Endocrinology 29 205-222.
42. Martin CC, Svitek CA, Oeser JK, Henderson E, Stein R & O'Brien RM 2003 Upstream stimulatory factor (USF) and neuroD/BETA2 contribute to islet-specific glucose-6-phosphatase catalytic subunit related protein (IGRP) gene expression. Biochemical Journal 371 675-686.
43. Marzluff WF 1990 Preparation of active nuclei. Methods in Enzymology 181 30-36.
44. Mason RM & Wahab NA 2003 Extracellular matrix metabolism in diabetic nephropathy. Journal of the American Society of Nephrology 14 1358-1373.
45. Mauer SM 1994 Structural functional correlations of diabetic nephropathy. Kidney International 45 612-622.
46. Mayr B & Montminy M 2001 Transcriptional regulation by the phosphorylation-dependent factor CREB. Nature Reviews. Molecular Cell Biology 2 599-609.
47. Medema RH, Wubbolts R & Bos JL 1991 Two dominant inhibitory mutants of p21 ras interfere with insulin-induced gene expression. Molecular and Cellular Biology 11 5963-5967.
48. Miller BS, Shankavaram UT, Horney MJ, Gore AC, Kurtz DT & Rosenzweig SA 1996 Activation of cJun NH2-terminal kinase/stress-activated protein kinase by insulin. Biochemistry 35 8769-8775.
49. Miyazaki A, Shimura H, Endo T, Haraguchi K & Onaya T 1999 Tumor necrosis factor-alpha and interferon-gamma suppress both gene expression and deoxyribonucleic acid-binding of TTF-2 in FRTL-5 cells. Endocrinology 140 4214-4220.
50. Mohn KL, Laz TM, Melby AE & Taub R 1990 Immediate-early gene expression differs between regenerating liver, insulin-stimulated H-35 cells, and mitogen-stimulated Balb/c 3T3 cells. Liver-specific induction patterns of gene 33, phosphoenolpyruvate carboxykinase, and the jun, fos, and egr families. Journal of Biological Chemistry 265 21914-21921.
51. Montminy M 1997 Transcriptional regulation by cyclic AMP. Annual Reviews in Biochemistry 66 807-822.
52. Nagase H & Woessner JF Jr 1999 Matrix metalloproteinases. Journal of Biological Chemistry 274 21491-21494.
53. Nakamura T, Fukui M, Ebihara I, Osada S, Tomino Y & Koide H 1994 Abnormal gene expression of matrix metalloproteinases and their inhibitor in glomeruli from diabetic rats. Renal Physiology and Biochemistry 17 316-325.
54. O'Brien RM & Granner DK 1996 Regulation of gene expression by insulin. Physiological Reviews 76 1109-1161.
55. O'Brien RM & Granner DK 2004 Gene regulation, In Diabetes Mellitus. A Fundamental and Clinical Text, pp. Eds D LeRoith, SI Taylor & JM Olefsky. Philadelphia: Lippincott-Raven.
56. O'Brien RM, Noisin EL, Suwanichkul A, Yamasaki T, Lucas PC, Wang JC, Powell DR & Granner DK 1995a Hepatic nuclear factor 3- and hormone-regulated expression of the phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein 1 genes. Molecular and Cellular Biology 15 1747-1758.
57. O'Brien RM, Printz RL, Halmi N, Tiesinga JJ & Granner DK 1995b Structural and functional analysis of the human phosphoenolpyruvate carboxykinase gene promoter. Biochimica et Biophysica Acta 1264 284-288.
58. O'Brien RM, Streeper RS, Ayala JE, Stadelmaier BT & Hornbuckle LA 2001 Insulin-regulated gene expression. Biochemical Society Transactions 29 552-558.
59. Oemar BS, Foellmer HG, Hodgdon-Anandant L & Rosenzweig SA 1991 Regulation of insulin-like growth factor I receptors in diabetic mesangial cells. Journal of Biological Chemistry 266 2369-2373.
60. Oikawa T & Yamada T 2003 Molecular biology of the Ets family of transcription factors. Gene 303 11-34.
61. Ortiz L, Zannini M, Di Lauro R & Santisteban P 1997 Transcriptional control of the forkhead thyroid transcription factor TTF-2 by thyrotropin, insulin, and insulin-like growth factor I. Journal of Biological Chemistry 272 23334-23339.
62. Osterby R 1996 Lessons from kidney biopsies. Diabetes/Metabolism Reviews 12 151-174.
63. Quandt K, Frech K, Karas H, Wingender E & Werner T 1995 MatInd and MatInspector: new fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Research 23 4878-4884.
64. Reaven GM 1997 The kidney: an unwilling accomplice in syndrome X. American Journal of Kidney Disease 30 928-931.
65. Reynolds JJ & Meikle MC 1997 The functional balance of metalloproteinases and inhibitors in tissue degradation: relevance to oral pathologies. Journal of the Royal College of Surgeons of Edinburgh 42 154-160.
66. Robey RB, Ma J & Santos AV 1999 Regulation of mesangial cell hexokinase activity by PKC and the classic MAPK pathway. American Journal of Physiology 277 F742-F749.
67. Roesler WJ & Park EA 1998 Hormone response units: one plus one equals more than two. Molecular and Cellular Biochemistry 178 1-8.
68. Rutter GA, White MR & Tavare JM 1995 Involvement of MAP kinase in insulin signalling revealed by non-invasive imaging of luciferase gene expression in single living cells (published erratum in Current Biology 1995 5 1072). Current Biology 5 890-899.
69. Sambrook J, Fritsch, EF & Maniatis EF 1989 Molecular Cloning: A Laboratory Manual. Plainview, NY: Cold Spring Harbor Laboratory Press.
70. Samson SL & Wong NC 2002 Role of Sp1 in insulin regulation of gene expression. Journal of Molecular Endocrinology 29 265-279.
71. Shaulian E & Karin M 2002 AP-1 as a regulator of cell life and death. Nature Cell Biology 4 E131-E136.
72. Sheets EE, Tsibris JC, Cook NI, Virgin SD, DeMay RM & Spellacy WN 1985 In vitro binding of insulin and epidermal growth factor to human endometrium and endocervix. American Journal of Obstetrics and Gynecology 153 60-65.
73. Sheetz MJ & King GL 2002 Molecular understanding of hyperglycemia's adverse affects for diabetic complications. Journal of the American Medical Association 288 2579-2588.
74. Shimano H 2002 Sterol regulatory element-binding protein family as global regulators of lipid synthetic genes in energy metabolism. Vitamins and Hormones 65 167-194.
75. Siddle K, Urso B, Niesler CA, Cope DL, Molina L, Surinya KH & Soos MA 2001 Specificity in ligand binding and intracellular signalling by insulin and insulin-like growth factor receptors. Biochemical Society Transaction 29 513-525.
76. Sivak JM & Fini ME 2002 MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Progress in Retinal Eye Research 21 1-14.
77. Streeper RS, Chapman SC, Ayala JE, Svitek CA, Goldman JK, Cave A & O'Brien RM 1998 A phorbol ester-insensitive AP-1 motif mediates the stimulatory effect of insulin on rat malic enzyme gene transcription. Molecular Endocrinology 12 1778-1791.
78. Suzuki T, Moriya T, Darnel AD, Takeyama J & Sasano H 2000 Immunohistochemical distribution of chicken ovalbumin upstream promoter transcription factor II in human tissues. Molecular and Cellular Endocrinology 164 69-75.
79. Treisman R 1990 Journey to the surface of the cell: Fos regulation and the SRE. EMBO Journal 14 4905-4913.
80. Vander Kooi BT, Streeper RS, Svitek CA, Oeser JK, Powell DR & O'Brien RM 2003 The Three insulin response sequences in the glucose-6-phosphatase catalytic subunit gene promoter are functionally distinct. Journal of Biological Chemistry 278 11782-11793.
81. Vihinen P & Kahari VM 2002 Matrix metalloproteinases in cancer: prognostic markers and therapeutic targets. International Journal of Cancer 99 157-166.
82. Vincenti MP 2001 The matrix metalloproteinase (MMP) and tissue inhibitor of metalloproteinase (TIMP) genes. Transcriptional and posttranscriptional regulation, signal transduction and cell-type-specific expression. Methods in Molecular Biology 151 121-148.
83. Visse R & Nagase H 2003 Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circulation Research 92 827-839.
84. Wasylyk B, Hahn SL & Giovane A 1993 The Ets family of transcription factors (published erratum in European Journal of Biochemistry 1993 215 907). European Journal of Biochemistry, 211 7-18.
85. Waterman MR 1994 Biochemical diversity of cAMP-dependent transcription of steroid hydroxylase genes in the adrenal cortex. Journal of Biological Chemistry 269 27783-27786.
86. Westermarck J & Kahari VM 1999 Regulation of matrix metalloproteinase expression in tumor invasion. FASEB Journal 13 781-792.
87. Wisdom R 1999 AP-1: one switch for many signals. Experimental Cell Research 253 180-185.
88. Yoon SO, Park SJ, Yun CH & Chung AS 2003 Roles of matrix metalloproteinases in tumor metastasis and angiogenesis. Journal of Biochemistry and Molecular Biology 36 128-137.